Ibuprofen Lysine Patent Expiration
Ibuprofen Lysine is used for closing a clinically significant patent ductus arteriosus in premature infants weighing between 500 and 1500g. It was first introduced by Recordati Rare Diseases Inc
Ibuprofen Lysine Patents
Given below is the list of patents protecting Ibuprofen Lysine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Neoprofen | US8415337 | Ibuprofen compositions and methods of making same | Mar 02, 2032 | Recordati Rare |
| Neoprofen | US6344479 | Method of preventing retinopathy of prematurity in a neonate |
Mar 20, 2021
(Expired) | Recordati Rare |
| Neoprofen | US6342530 | Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt |
Nov 14, 2020
(Expired) | Recordati Rare |
Ibuprofen Lysine's Family Patents
Explore Our Curated Drug Screens
Ibuprofen Lysine Generic API Manufacturers
Only one generic application has been filed for Ibuprofen Lysine.
Given below is the list of companies who have filed for Ibuprofen Lysine generic, along with the locations of their manufacturing plants worldwide.
1. XGEN PHARMS
Xgen Pharmaceuticals Djb Inc has filed for 1 generic for Ibuprofen Lysine. Given below are the details of the strengths of this generic introduced by Xgen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE/2ML (EQ 10MG BASE/ML) | injectable | Prescription | INTRAVENOUS | AP | Mar 30, 2016 |